Medavie Blue Cross launches pharmacogenetic testing pilot
Medavie Blue Cross has launched a pharmacogenetic testing pilot to help group plan members get the best medication specifically for them. The program will leverage GeneYouIn Inc.’s Pillcheck™ system.
The pharmacogenetic test requires a simple cheek swab. The Pillcheck system then uses pharmacogenetics, which combines pharmacology and genomics, to analyze the patient’s DNA and determine how t...
by The IJ Staff May 22, 2019, 11:30 a.m.